Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-08

Clinical Trial Update: Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for SCI [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety of cultured allogeneic umbilical cord-derived mesenchymal stem cells for spinal cord injury. The study is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cultured allogeneic umbilical cord-derived mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: The Foundation for Orthopaedics and Regenerative Medicine | Conditions: Spinal Cord Injuries | Phase 1 | Status: RECRUITING